Moderator(s)
Prof. Dr. D. Tilki (DE)
Presenter(s)
Prof. B. Tombal (BE)
Prof. Dr. H.G. Van Der Poel (NL)
PARP inhibitors in prostate cancer treatment is still a relatively new topic for most urologists. With this PARPi curriculum we offer urologists an educational programme addressing the following learning objectives:
1. Understanding the rationale for PARPi combinations as potential PCa treatments
2. Getting more insights on patient selection/identification for potential treatment with PARPi combinations
3. Learn the latest developments by discussing ongoing clinical trial design exploring PARPi combinations in Prostate Cancer
In a series of webinars we will tackle its role in prostate cancer treatment, discussing the latest evidence and a practical guide in how to use it in your daily practice.
At a glance:
Publication date: February 2022
Available languages: English
Topic: Prostate cancer
